April 4, 2024 – April 5, 2024

San Diego Mission Bay Resort
San Diego, California

In-Person
Earn up to 9.5 CME/CE credits
swoosh
swoosh

ACCREDITATION

TARGET AUDIENCE

This activity is intended for hematologists, hematologists/oncologists, internists, physician assistants, nurse practitioners, nurses, pharmacists, and all members of the healthcare team who treat or manage patients with acute leukemia or myelodysplastic syndromes (MDS).

 

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to: [LIST] [ITEM]Identify recent advances in assessing, treating, and managing patients with MDS [ITEM]Appraise the role of novel therapeutic strategies in the treatment and management of ALL [ITEM]Differentiate new insights in the basic biology of acute leukemia and their role in new therapeutic approaches [ITEM]Assess practice-changing updates in the treatment continuum of AML [ITEM]Evaluate key evidence that addresses challenges in bone marrow transplantation and the prevention and management of GVHD [ITEM]Explain how recent progress can be integrated into individualized treatment approaches for patients with acute leukemia [/LIST]

 

ACCREDITATION STATEMENTS

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. [JALOGOGAME][PIM]

[bold]Physician Continuing Medical Education [/bold] The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 9.5 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 9.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. [bold]California Board of Registered Nursing [/bold] Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 9.5 contact hours. [bold]Continuing Physician Assistant Education [/bold] AAPA accepts certificates of participation for educational activities certified for [italic]AMA PRA Category 1 Credits™[/italic]. from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 9.5 Category 1 credits for completing this activity. [bold]Continuing Pharmacy Education [/bold] Postgraduate Institute for Medicine designates this continuing education activity for 9.5 contact hours (.95 CEUs) of the Accreditation Council for Pharmacy Education. [bold]DISCLOSURE OF CONFLICTS OF INTEREST [/bold] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.